Issue 19, 2025
From the journal:

Nanoscale

Correction: Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer

Zhe Yang,a   Huiyan Luo,ab   Zhong Cao,a   Ya Chen,a   Jinbiao Gao,a   Yingqin Li,a   Qing Jiang,a   Ruihua Xu*b  and  Jie Liu*a  

* Corresponding authors

a Department of Biomedical Engineering, School of Engineering, Sun Yat-sen University, Guangzhou, Guangdong 510006, China
E-mail: liujie56@mail.sysu.edu.cn

b Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Guangzhou, Guangdong 510060, China
E-mail: xurh@sysucc.org.cn

Abstract

Correction for ‘Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer’ by Zhe Yang et al., Nanoscale, 2016, 8, 11543–11558, https://doi.org/10.1039/C6NR01749E.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D5NR90081F
Article type
Correction
Submitted
22 Apr 2025
Accepted
22 Apr 2025
First published
02 May 2025
This article is Open Access
Creative Commons BY license

Nanoscale, 2025,17, 12516-12517

Permissions

Request permissions

Correction: Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer

Z. Yang, H. Luo, Z. Cao, Y. Chen, J. Gao, Y. Li, Q. Jiang, R. Xu and J. Liu, Nanoscale, 2025, 17, 12516 DOI: 10.1039/D5NR90081F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements